FDA
- Status: approved
Azithromycin plus piperaquine phosphate (Azithromycin plus piperaquine phosphate) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Papua New Guinea Institute of Medical Research is the originator. The local marketing authorisation holder may differ — check the official source linked above.